Release Date: 31/01/11 13:31 Summary: Further Extension Agreement reached with Note holder Price Sensitive: No Download Document 72.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%